摘要
为研究脂质代谢紊乱与血浆凝血纤溶活性的关系,分别测定了61例高脂血症患者(混合性高脂血症16例和单纯性高甘油三酯血症45例)的血清脂质和血浆反映凝血纤溶活性的有关指标,并与18例正常人对比。结果发现,高脂血症患者的血浆纤溶酶原激活剂抑制物-1、凝血因子VII和凝血因子X活性明显高于正常对照组(P<0.05~0.001),组织型纤溶酶原激活物活性明显低于正常对照组(P<0.05)。血清甘油三酯水平与血浆纤溶酶原激活物抑制剂-1、因子VII和因子X活性是显著的正相关性(P<0.05~0.001),与组织型纤溶酶原激活物活性是显著的负相关性(P<0.01);血清胆固醇水平与血浆纤维蛋白原水平和纤溶酶原激活物抑制剂-1活性呈显著的正相关性(P<0.05)。结果提示,脂质代谢紊乱,特别是高甘油三酯血症可增加体内凝血活性,降低纤溶活性,有利于血栓形成,对动脉粥样硬化的发生和发展有不利的影响。
Aim To ivestigate the association of lipid metabolism disturbance with haemostatic activity and fibrinolytic activity.Methods Serum lipids,some plasma haemostatic and fibrinolytic parameters were determined in 61 pa-tients with hyperlipidemia(hypertriglyceridemia in 45and mixed hyperlipidemia in 16)and compaerd with those in 18 healthy controls.Results The plasma activities of type-1 plasmino-gen activitor inhibitor(PAI-1),coagulation factor VII (F VII)and X(F X)were significantly higher,tissue type plasminogen activitor(tPA)was significantly lower in hyperlipidemic patients when compared with those in healthy controls(P<0.05~0.001). Fur-thermore serum triglyceride level was positively corre-lated with plasma activities of PAI-1,F VII and F X(P <0.05~0.001),and negatively correlated with tPA activity(P<0.01).Serum cholesterol level was also positively correlated with plasma fibrinogen level and PAI-1 activity(P<0.05).Conclusion Hyperlipidemia,especially hyper-triglyceridemia may increase coagulation activity and decrease fibrinolytic activity,benefiting the formation of thrombosis.Therefore,hyperlipidemia is an im portant risk factor for atherosclerosis.
出处
《中国动脉硬化杂志》
CAS
CSCD
1998年第4期333-335,共3页
Chinese Journal of Arteriosclerosis
关键词
血脂
高甘油三酯血症
动脉粥样硬化
PAI-1
Serum lipid
Hypertriglyceridemia
Haemostatic activity
Fibrinolytic activity
Atherosclerosis